GeneMatch designed to speed up Alzheimer’s trial recruitmentDecember 9, 2015Alzheimer's & CognitionGeriatricsNeurology
New analyses of data keep hope alive for Alzheimer’s drug gantenerumabDecember 5, 2015Alzheimer's & CognitionGeriatricsNeurology
CTAD: Anti-tau vaccine demonstrated safety, immunogenicity in phase I studyDecember 2, 2015Alzheimer's & CognitionGeriatricsNeurology
BRCA1 may have an impact in Alzheimer’s diseaseDecember 1, 2015Alzheimer's & CognitionGeriatricsNeurology
CTAD: New aducanumab subanalysis bolsters phase III trials in very mild Alzheimer’sNovember 17, 2015Alzheimer's & CognitionGeriatricsNeurology
CTAD: Sigma-1 receptor agonist passes muster in small Alzheimer’s trialNovember 17, 2015Alzheimer's & CognitionGeriatricsNeurology
Omega-3 plus physical, mental training prevented cognitive decline for 3 yearsNovember 7, 2015Alzheimer's & CognitionGeriatricsNeurology
High-risk patients fared best in lifestyle intervention trial for cognitive declineNovember 5, 2015Alzheimer's & CognitionGeriatricsNeurology
Raloxifene ineffective for treating AD patientsNovember 4, 2015Alzheimer's & CognitionGeriatricsNeurology
ADHD in the elderly: An unexpected diagnosisOctober 30, 2015Alzheimer's & CognitionGeriatricsNeurology
Trial to prove utility of amyloid imaging seeks physicians for referralsOctober 28, 2015Alzheimer's & CognitionGeriatricsNeurology
FRONTIER screen distinguishes frontotemporal dementia from Alzheimer’sOctober 8, 2015Alzheimer's & Cognition
Intravenous immunoglobulin briefly staved off progression to Alzheimer’sOctober 8, 2015Alzheimer's & Cognition
